Related Experiment Video
Updated: Mar 28, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
25.5K
Additional thoughts on the new treatment Kybella
Seminars in Cutaneous Medicine and Surgery
|December 19, 2015
Summary
Kybella, an injectable treatment for submental fat, offers a new nonsurgical option for double chin reduction. This discussion addresses common misconceptions surrounding this exciting new cosmetic procedure.
Area of Science:
- Cosmetic dermatology
- Injectable treatments
Background:
- Submental fullness, or double chin, is a common aesthetic concern.
- Nonsurgical treatments are increasingly sought after for aesthetic concerns.
Purpose of the Study:
- To discuss the recent approval of Kybella, an injectable treatment for submental fat.
- To address potential misconceptions surrounding Kybella treatment.
Main Methods:
- Literature review on submental fat treatments.
- Analysis of patient concerns and expectations regarding Kybella.
Main Results:
- Kybella offers a novel, nonsurgical approach to reducing submental fullness.
- Patient excitement is tempered by a need for clear information and realistic expectations.
Conclusions:
- Kybella represents a significant advancement in nonsurgical aesthetic treatments.
- Addressing misconceptions is crucial for patient satisfaction and safe adoption of Kybella.
Related Concept Videos
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:56Treatment Resistent Cancers
1.5K
1.5K
01:20Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K